Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    

ARIAD PHARMACEUTICALS, INC.
Mes dernières consult.
Most popular
  Report  
 SummaryNewsCompany 
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge,... 
More about the company
Latest news on ARIAD PHARMACEUTICALS, INC
2017ARIAD PHARMACEUTICALS : Announces Submission of Marketing Authorization Applicat..
BU
2017ARIAD PHARMACEUTICALS : Enters into Definitive Agreement to Be Acquired by Taked..
PU
2017ARIAD PHARMACEUTICALS : Takeda to Acquire ARIAD Pharmaceuticals, Inc.
PU
2017ARIAD PHARMACEUTICALS : Acquisition May Not Be in the Best Interests of ARIA Sha..
PR
2017ARIAD SHAREHOLDER NOTICE : Faruqi & Faruqi, LLP Announces the Investigation of A..
PR
2017Brower Piven Commences An Investigation Into The Proposed Sale Of ARIAD Pharm..
BU
2017ARIAD PHARMACEUTICALS, INC. : Ariad Pharmaceuticals Cash Acquisition by Takeda P..
AC
2017Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal
RE
2017HARWOOD FEFFER LLP : Announces Investigation of ARIAD Pharmaceuticals, Inc.
PR
2017ARIAD PHARMACEUTICALS, INC. Rigrodsky & Long, P.A. Announces Investigation Of..
BU
More news
Sector news : Bio Therapeutic Drugs
04/25Currency and pricing squeeze GSK as new shingles vaccine shines
RE
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
20173 THINGS IN BIOTECH YOU SHOULD LEARN : April 30, 2017 
2017SNIPPET ROUNDUP : Aerie Stumbles On Safety; Stada Is Sold At Last 
2017First-Quarter Deal Making Shows Glimmers Of Growth 
2017WHAT TO WATCH IN Q2 : Upcoming Healthcare Regulatory Events 
2017Roche Looks Ready To Rule Another Cancer Niche 
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | US04033A1007 | 4-Traders
Managers
NameTitle
Christophe M. Bianchi Co-President
Paris Panayiotopoulos Co-President & Director
Nicholas Ventresca Chief Information Officer & Senior Vice President
Elona Kogan Director & General Counsel
Manmeet Singh Soni Director
Sector and Competitors
1st jan.Capitalization (M$)
ARIAD PHARMACEUTICALS, INC.0
GILEAD SCIENCES3.31%96 498
VERTEX PHARMACEUTICALS5.89%40 290
REGENERON PHARMACEUTICALS-15.95%34 033
GENMAB20.17%12 599
BEIGENE LTD (ADR)73.75%9 087